Jonathan G. Drachman, President and CEO at Neoleukin Therapeutics, Inc. (NLTX), bought 1,499,694 shares at $8.40 ($2.0M) on 2019-12-20, disclosed to the SEC on 2019-12-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,261,600 | $0 | 0.0% |
| 2 | $8.40 | 119,047 | $1000K | 50.0% |
| 3 | $8.40 | 119,047 | $1000K | 50.0% |
| Total | $1.33 avg | 1,499,694 | $2.0M | 100% |
| Filing → |
| NLTX | BUY | 2021-06-07 | $475K | — | Filing → |
| NLTX | BUY | 2019-09-11 | $1.6M | — | Filing → |
| SGEN | SELL | 2018-03-07 | $725K | — | Filing → |